Last 18,300 KRW
Change Today -100.00 / -0.54%
Volume 101.4K
001060 On Other Exchanges
Symbol
Exchange
Korea SE
Korea SE
Korea SE
As of 2:18 AM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).

jw pharmaceutical (001060) Snapshot

Open
18,700
Previous Close
18,400
Day High
18,800
Day Low
17,850
52 Week High
05/3/13 - 20,950
52 Week Low
07/26/12 - 11,048
Market Cap
234.0B
Average Volume 10 Days
166.7K
EPS TTM
-1,881.00
Shares Outstanding
12.8M
EX-Date
12/27/12
P/E TM
--
Dividend
125.00
Dividend Yield
0.68%
Current Stock Chart for JW PHARMACEUTICAL (001060)

Related News

No related news articles were found.

jw pharmaceutical (001060) Related Businessweek News

No Related Businessweek News Found

jw pharmaceutical (001060) Details

JW Pharmaceutical engages in the production and sale of pharmaceutical products primarily in South Korea. Its products comprise diabetic agents, urology agents, CNS products, nephrology agents, analgesics, antipyretics, cold remedy products, antidote agents, antimicrobials, anticancer agents, antifungal agents, cardiovascular agents, gastrointestinal agents, multivitamins and antianemic agents, contact lens care and ophthalmic agents, topicals, nephrology agents, amino acid solutions, flexible I.V. containers, I.V. solutions, respiratory agents, and OBGY agents. The company also licenses its chemical entities technologies for the treatment of breast cancer and irritable bowel syndrome, as well as offers active pharmaceutical ingredients and bulk pharmaceutical products. It also exports its products to European union and Japan. The company was formerly known as Choongwae Pharma Corporation and changed its name to JW Pharmaceutical on April 21, 2011. JW Pharmaceutical was founded in 1945 and is based in Seoul, South Korea.

1,003 Employees
Last Reported Date: 04/1/13
Founded in 1945

jw pharmaceutical (001060) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jw pharmaceutical (001060) Key Developments

JW Pharmaceutical Corporation, Annual General Meeting, Mar 15, 2013

JW Pharmaceutical Corporation, Annual General Meeting, Mar 15, 2013., at 09:00 Korea Standard Time. Location: dong, Seocho-gu. Agenda: To consider audit report and sales reporting; to consider the financial statement; to consider the appointment of director; and to consider the directors remuneration limit.

JW Pharmaceutical, Annual General Meeting, Mar 23, 2012

JW Pharmaceutical, Annual General Meeting, Mar 23, 2012.

JW Pharmaceutical(KOSE:A001060) dropped from KOSPI 200 Index

JW Pharmaceutical will be removed from the KOSPI 200 Index, effective June 10, 2011.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
001060:KS 18,300.00 KRW -100.00

001060 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 001060.
View Industry Companies
 

Industry Analysis

001060

Industry Average

Valuation 001060 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JW PHARMACEUTICAL, please visit www.cwp.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.